Article Information
History
- August 30, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- ZH McMahan1,*,†,
- S Kulkarni2,*,
- F Andrade1,
- J Perin3,
- C Zhang2,
- JE Hooper4,
- FM Wigley1,
- A Rosen1,
- PJ Pasricha2,** and
- L Casciola-Rosen1,**
- 1Johns Hopkins University, Division of Rheumatology
- 2Johns Hopkins University, Division of Gastroenterology
- 3Johns Hopkins University, Department of Biostatistics
- 4Johns Hopkins University, Department of Pathology
- ↵†Corresponding author:
Zsuzsanna McMahan, MD, MHS, 5200 Eastern Avenue, Suite 5200, Mason F. Lord Building, Center Tower, Baltimore, MD 21224, Tel: 410-550-2003; Fax: 410-550-2072, E-mail: zmcmaha1{at}jhmi.edu
Posted August 30, 2022.
Anti-Gephyrin antibodies: A novel specificity in patients with systemic sclerosis and lower bowel dysfunction
